Pure Global

Ventana Medical Systems Inc - Manufacturer Profile

Explore comprehensive manufacturer profile for Ventana Medical Systems Inc through Pure Global AI's free Australia TGA ARTG medical device database. This company has manufactured 28 medical devices registered with TGA ARTG across 3 device classes. This manufacturer is based in United States of America. Their registration history spans from Jul 19, 2010 to May 06, 2024.

This page provides detailed insights including recent device registrations, risk class distribution (Class IIa: 10, Class IIb: 14, Class I: 4), and complete regulatory information from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices.

Free Manufacturer Profile
Powered by Pure Global AI
28 Devices
3 Device Classes
Ventana Medical Systems Inc
Manufacturer โ€ข United States of America
28
Total Devices
3
Device Classes
2010
Earliest
2024
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Device Registrations
Latest 10 TGA ARTG device registrations

Software IVDs

Class I
May 06, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Software IVDs

ARTG 447765

Class I
May 06, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MSH2 (G219-1129) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

ARTG 441012

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MLH1 (M1) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-PMS2 (A16-4) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MSH6 (SP93) Rabbit Monoclonal Primary Antibody - Immunohistology cell marker IVDs

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MSH2 (G219-1129) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-PMS2 (A16-4) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

ARTG 441011

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MSH6 (SP93) Rabbit Monoclonal Primary Antibody - Immunohistology cell marker IVDs

ARTG 441013

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

VENTANA anti-MLH1 (M1) Mouse Monoclonal Primary Antibody - Immunohistology cell marker IVDs

ARTG 441010

Class IIb
Feb 14, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Risk Class Distribution
Devices by risk class
Class I
4
14.3% of total
Class IIa
10
35.7% of total
Class IIb
14
50.0% of total